Cefprozil
Edina Avdic, Pharm.D.
,
Paul A. Pham, Pharm.D.
INDICATIONS
INDICATIONS
INDICATIONS
FDA
FDA
FDA
Upper respiratory tract infections (
acute bronchitis
,
acute exacerbation of chronic bronchitis
[AECB],
otitis media
,
pharyngitis,
acute sinusitis
,
tonsillitis
)
Secondary bacterial infection of
acute bronchitis
and
AECB
caused by
S. pneumoniae
,
H. influenzae
and
M. catarrhalis
.
Uncomplicated skin and skin structure infections caused by MSSA and and
S. pyogenes.
NON-FDA APPROVED USES
NON-FDA APPROVED USES
NON-FDA APPROVED USES
Community-acquired pneumonia
(
CAP
)
There's more to see -- the rest of this topic is available only to subscribers.
© 2000–2025 Unbound Medicine, Inc. All rights reserved
All content is protected by copyright and may not be used for AI model training or other unauthorized purposes.